Company profile · Mainz, Germany

ORGENTEC Diagnostika

Autoimmunity Diagnostics, Infectious Disease Testing, Immunology Assays, IVD, and Laboratory Diagnostics · Diagnostics platform

ORGENTEC Diagnostika runs autoimmune assay development, infectious disease testing, and immunodiagnostics platform work in Mainz, Germany.

Lead
Gregoire Allaz (verified ↗)
Address
Carl-Zeiss-Strasse 49-51, 55129 Mainz, Germany (source ↗)
Compliance
ISO-13485
Last reviewed
22 Mar 2026 (2mo ago)
Scale
Diagnostics platform
Capabilities
Autoimmune Assay Development · Infectious Disease Testing · Immunodiagnostics Platform Work
Founded
1988
Headcount
1001-5000
LinkedIn
Company page (open ↗)
Site and address
Clinical profileSTATUS: VERIFIED MARCH 2026

Gregoire Allaz

Chief Executive Officer

Check official leadership source
Full addressCarl-Zeiss-Strasse 49-51, 55129 Mainz, Germany
Site coordinatesVerification evidence is still being completed.
Review cycleMay 2026
Physical site source

Official ORGENTEC materials listing the Mainz address.

Open source
Operating profile

Diagnostics platform

Mainz, Germany. Autoimmunity Diagnostics, Infectious Disease Testing, Immunology Assays, IVD, and Laboratory Diagnostics. Review completed on 22 Mar 2026.

2026 technical specializationAutoimmunity Diagnostics, Infectious Disease Testing, Immunology Assays, IVD, and Laboratory Diagnostics
Core capabilities
Autoimmune Assay DevelopmentInfectious Disease TestingImmunodiagnostics Platform Work
Governance

German diagnostics and IVD oversight

Official leadership disclosure, Official Mainz address disclosure, IVD platform claim

Editorial note

Autoimmunity Diagnostics, Infectious Disease Testing, Immunology Assays, IVD, and Laboratory Diagnostics

ORGENTEC Diagnostika is published because official company materials confirm current leadership, Mainz operating address, and a real immunodiagnostics platform.

Editorial note

ORGENTEC Diagnostika is published because official company materials confirm current leadership, Mainz operating address, and a real immunodiagnostics platform.

FULL TRUST REVIEW COMPLETE
Shown only when all seven trust checks are fully mapped in the directory.
Current review cycleMarch 2026Last reviewed: 22 March 2026
Capabilities

Core capabilities

Primary declared technical activities and areas of operating focus.

Autoimmune Assay Development
Infectious Disease Testing
Immunodiagnostics Platform Work
Verification source dossier

Verification source dossier

Official source set used to support leadership, physical-site, certification, and watch-note evidence.

Leadership evidenceOfficial ORGENTEC group materials naming Gregoire Allaz as Chief Executive Officer.Source origin: orgentec.comOpen source
Supporting evidenceOfficial ORGENTEC press material confirming the Mainz address.Source origin: orgentec.comOpen source
Physical-site evidenceOfficial ORGENTEC materials listing the Mainz address.Source origin: orgentec.comOpen source
Infrastructure

Declared infrastructure

Immunodiagnostics workflow
Assay development systems
Diagnostics manufacturing and support tools
Regulatory posture

Quality system coverage

GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.

GMP
REVIEW IN PROGRESS 2026
GLP
REVIEW IN PROGRESS 2026
ISO-13485
VERIFIED ACTIVE 2026
FDA-Inspected
REVIEW IN PROGRESS 2026
Verification history

Verification history

22 Mar 2026: Executive identity confirmed via official management disclosure.
22 Mar 2026: Full trust review completed.
FAQ

Frequently asked questions

Where is ORGENTEC Diagnostika located?
ORGENTEC Diagnostika operates from Carl-Zeiss-Strasse 49-51, 55129 Mainz, Germany, Mainz, Germany.
Who runs ORGENTEC Diagnostika?
ORGENTEC Diagnostika is led by Gregoire Allaz, Chief Executive Officer. Verified 22 Mar 2026.
What does ORGENTEC Diagnostika do?
ORGENTEC Diagnostika runs autoimmune assay development, infectious disease testing, and immunodiagnostics platform work in Mainz, Germany. Core capabilities: Autoimmune Assay Development, Infectious Disease Testing, Immunodiagnostics Platform Work.
Editorial context

Related technical briefs

Briefs that name Mainz as a covered market or city.